Synthgene

申基生物

Synthgene

Biotech/Healthcare

Founded in 2018, Shenji Biology focuses on providing integrated solutions for upstream raw materials in the life sciences. The company has established technology platforms for antibody discovery, mRNA drug-substance production, mRNA-LNP formulation processes, oligonucleotide production, and…

Latest round: Series C (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-03-01